[HTML][HTML] Role of the NLRP3 inflammasome in cancer

M Moossavi, N Parsamanesh, A Bahrami, SL Atkin… - Molecular cancer, 2018 - Springer
Inflammasomes are large intracellular multi-protein signalling complexes that are formed in
the cytosolic compartment as an inflammatory immune response to endogenous danger …

[HTML][HTML] Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells

U Testa, G Castelli, E Pelosi - Cancers, 2018 - mdpi.com
Lung cancer causes the largest number of cancer-related deaths in the world. Most (85%) of
lung cancers are classified as non-small-cell lung cancer (NSCLC) and small-cell lung …

[HTML][HTML] The prognostic role of circulating tumor cells (CTCs) in lung cancer

J Kapeleris, A Kulasinghe, ME Warkiani, I Vela… - Frontiers in …, 2018 - frontiersin.org
Lung cancer affects over 1. 8 million people worldwide and is the leading cause of cancer
related mortality globally. Currently, diagnosis of lung cancer involves a combination of …

[HTML][HTML] The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non‑small cell lung cancer

Y Chen, NW Mathy, H Lu - Molecular medicine reports, 2018 - spandidos-publications.com
Malignant pleural effusion (MPE) is a severe medical condition, which can result in
breathlessness, pain, cachexia and reduced physical activity. It can occur in almost all types …

[HTML][HTML] Quantum dot based nano-biosensors for detection of circulating cell free miRNAs in lung carcinogenesis: from biology to clinical translation

RD Singh, R Shandilya, A Bhargava, R Kumar… - Frontiers in …, 2018 - frontiersin.org
Lung cancer is the most frequently occurring malignancy and the leading cause of cancer-
related death for men in our country. The only recommended screening method is clinic …

A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment

S Bamji-Stocke, V van Berkel, DM Miller, HB Frieboes - Metabolomics, 2018 - Springer
Introduction Lung cancer continues to be the leading cause of cancer-related mortality
worldwide. Early detection has proven essential to extend survival. Genomic and proteomic …

Chronic obstructive pulmonary disease and lung cancer: underlying pathophysiology and new therapeutic modalities

MS Eapen, PM Hansbro, AK Larsson‑Callerfelt… - Drugs, 2018 - Springer
Chronic obstructive pulmonary disease (COPD) and lung cancer are major lung diseases
affecting millions worldwide. Both diseases have links to cigarette smoking and exert a …

[HTML][HTML] MiR-598 suppresses invasion and migration by negative regulation of derlin-1 and epithelial-mesenchymal transition in non-small cell lung cancer

F Yang, K Wei, Z Qin, W Liu, C Shao, C Wang… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: MicroRNAs regulate a wide range of biological processes of non-small
cell lung cancer (NSCLC). Although miR-598 has been reported to act as a suppressor in …

[HTML][HTML] PLOD3 promotes lung metastasis via regulation of STAT3

JH Baek, HS Yun, GT Kwon, JY Kim, CW Lee… - Cell death & …, 2018 - nature.com
Abstract Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD3), a membrane-bound
homodimeric enzyme, hydroxylates lysyl residues in collagen-like peptides; however, its role …

A National Cancer Database analysis of radiofrequency ablation versus stereotactic body radiotherapy in early-stage non–small cell lung cancer

A Lam, EJ Yoshida, K Bui, D Fernando… - Journal of Vascular and …, 2018 - Elsevier
Purpose To compare overall survival (OS) after radiofrequency (RF) ablation and
stereotactic body radiotherapy (SBRT) at high-volume centers in patients with early-stage …